483 Acadia Pharmaceuticals Jan 2021

483 Acadia Pharmaceuticals Jan 2021

Kaitlyn Dang FDA, Lakecha Lewis FDA$119.00 - Available Now

FDA investigators audited the Acadia Pharmaceuticals - San Diego, CA, United States facility and issued inspectional observations (via FDA 483) on 27 Jan 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Jan 2021
  • Location: San Diego, United States
  • FEI: 3005617555
Add To Cart